Myomo (MYO) Interest & Investment Income (2016 - 2025)
Myomo (MYO) reported Interest & Investment Income of -$9743.0 for Q3 2025, down 112.82% on a YoY basis from $76020.0 in Q3 2024, and down 109.14% quarter-over-quarter from $106549.0 in Q2 2025.
Myomo (MYO) Interest & Investment Income (2016 - 2025) Analysis & Trends
Myomo has reported Interest & Investment Income for 10 years, with the latest figure at -$9743.0 in Q3 2025.
- For the quarter ending Q3 2025, Interest & Investment Income fell 112.82% year-over-year to -$9743.0; the trailing twelve-month figure through Sep 2025 stood at $358828.0 (down 15.92% YoY), and the FY2024 full-year result was $388586.0, down 5.29% from the prior year.
- Interest & Investment Income for Q3 2025 stood at -$9743.0, down from $106549.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $191991.0 in Q1 2025, with the low at -$9743.0 in Q3 2025.
- Historically, Interest & Investment Income has averaged $62000.1 across 5 years, with a median of $70031.0 in 2024.
- Annual changes were most pronounced in 2021 — Interest & Investment Income plunged 113.56% — and 2023, when it jumped 47852.22%.
- Myomo's Interest & Investment Income stood at $11805.0 in 2021, then soared by 245.18% to $40748.0 in 2022, then soared by 165.59% to $108221.0 in 2023, then sank by 35.29% to $70031.0 in 2024, then plunged by 113.91% to -$9743.0 in 2025.
- The last three Interest & Investment Income figures came in at -$9743.0 (Q3 2025), $106549.0 (Q2 2025), and $191991.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 33.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 40.98 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Myomo | 45.01 Mn | 26.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -9,743.00 |
| Jun 30, 2025 | 106,549.00 |
| Mar 31, 2025 | 191,991.00 |
| Dec 31, 2024 | 70,031.00 |
| Sep 30, 2024 | 76,020.00 |
| Jun 30, 2024 | 107,242.00 |
| Mar 31, 2024 | 135,293.00 |
| Dec 31, 2023 | 108,221.00 |
| Sep 30, 2023 | 112,300.00 |
| Jun 30, 2023 | 103,439.00 |
| Mar 31, 2023 | 86,314.00 |
| Dec 31, 2022 | 40,748.00 |
| Sep 30, 2022 | 33,958.00 |
| Jun 30, 2022 | 13,845.00 |
| Mar 31, 2022 | 180.00 |
| Dec 31, 2021 | 11,805.00 |
| Sep 30, 2021 | -4,055.00 |
| Jun 30, 2021 | -6,018.00 |
| Mar 31, 2021 | -119.00 |
| Dec 31, 2020 | 1,867.00 |